Ardevora Asset Management’s Bristol-Myers Squibb BMY Stock Holding History

Ardevora Asset Management’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-518,088	Closed	-$26.9M	–	112
2018 Q4	$26.9M	Buy	518,088 +62,200	+14%	+$3.34M	0.81%	84
2018 Q3	$28.3M	Sell	455,888 -46,900	-9%	-$2.78M	0.79%	83
2018 Q2	$27.8M	Buy	502,788 +37,688	+8%	+$2.04M	0.78%	83
2018 Q1	$29.4M	Buy	465,100 +2,700	+0.6%	+$174K	0.88%	73
2017 Q4	$28.3M	Hold	462,400	–	–	0.85%	85
2017 Q3	$29.5M	Sell	462,400 -6,700	-1%	-$391K	0.88%	73
2017 Q2	$26.1M	Buy	469,100 +96,400	+26%	+$5.25M	0.82%	83
2017 Q1	$20.3M	Buy	372,700 +20,400	+6%	+$1.12M	0.67%	102
2016 Q4	$20.6M	Buy	+352,300	New	+$19.3M	0.74%	92

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Ardevora Asset Management's BMY Position: Q1 2019 in Review

Ardevora Asset Management sold out of Bristol-Myers Squibb (BMY) in Q1 2019, closing a stake of 518,088 shares — an estimated $26.9M sold.

Ardevora Asset Management first reported a position in BMY in Q4 2016 and held it in 9 quarters. The position peaked at $29.5M in Q3 2017. 1,814 funds tracked by Wall St. Rank hold BMY as of Q1 2019.

Ardevora Asset Management reported no remaining Bristol-Myers Squibb position as of Q1 2019 after selling out during the quarter.
Ardevora Asset Management sold 518,088 Bristol-Myers Squibb shares in Q1 2019, an estimated $26.9M.
Ardevora Asset Management first reported a position in Bristol-Myers Squibb in Q4 2016 and held it in 9 quarters.
Ardevora Asset Management's Bristol-Myers Squibb position peaked at $29.5M in Q3 2017.
1,814 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2019.

Based on Ardevora Asset Management's 13F filing for Q1 2019, filed 24 Apr 2019.